AmpliPhi Biosciencess C3J Logo

Armata has joined together two seasoned drug development teams, AmpliPhi Biosciences and C3J Therapeutics, to tackle the global and increasingly serious threat of antimicrobial-resistant bacterial infections. Driven by rigorous and innovative science, Armata is developing high-impact, best-in-class bacteriophage therapeutics with the potential to save millions of lives.

Armata Pharmaceuticals


todd patrick
Todd R. Patrick
Chief Executive Officer
Read Bio »
Brian Varnum
Brian Varnum, Ph.D.
President and Chief Development Officer
Read Bio »
steve martin
Steve Martin
Chief Financial Officer
Read Bio »
duane morris
Duane Morris
Vice President of Operations
Read Bio »
Heather Jones
Heather D. Jones, MD
Vice President, Clinical Development
Read Bio »